Growing community of inventors

Talence, France

Andreas Bikfalvi

Average Co-Inventor Count = 3.43

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 14

Andreas BikfalviHerve Prats (2 patents)Andreas BikfalviAlexandre Dubrac (2 patents)Andreas BikfalviNatacha Betz (2 patents)Andreas BikfalviGerard Deleris (2 patents)Andreas BikfalviCathy Quemener (1 patent)Andreas BikfalviEric Lacazette (1 patent)Andreas BikfalviMartin Hagedorn (0 patent)Andreas BikfalviLaurent Dumartin (0 patent)Andreas BikfalviHervé Prats (0 patent)Andreas BikfalviAndreas Bikfalvi (4 patents)Herve PratsHerve Prats (2 patents)Alexandre DubracAlexandre Dubrac (2 patents)Natacha BetzNatacha Betz (2 patents)Gerard DelerisGerard Deleris (2 patents)Cathy QuemenerCathy Quemener (1 patent)Eric LacazetteEric Lacazette (1 patent)Martin HagedornMartin Hagedorn (0 patent)Laurent DumartinLaurent Dumartin (0 patent)Hervé PratsHervé Prats (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Universitë De Bordeaux (3 from 215 patents)

2. Commissariat a L'energie Atomique (2 from 3,559 patents)

3. Institut National De La Sante Et De La Recherche Medicale (2 from 1,748 patents)

4. Université Victor Segalen—bordeaux 2 (1 from 11 patents)

5. Universite Victor Sagalen Bordeaux 2 (1 from 1 patent)

6. Inserm (Institut National De La Sante Et De La Recherche Medicale) (49 patents)


4 patents:

1. 8940702 - Mutants PF4 polypeptides exhibiting an increased anti-angiogenic activity

2. 8481033 - Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1)

3. RE44022 - Cyclic peptides, method for preparing and use as angiogenesis inhibitors or activators

4. 7199100 - Cyclic peptides, method for preparing and use as angiogenesis inhibitors or activator

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/17/2026
Loading…